Option Care Health, Inc. (NASDAQ:OPCH) Position Reduced by Riverbridge Partners LLC

Riverbridge Partners LLC reduced its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 13.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 1,492,469 shares of the company's stock after selling 224,150 shares during the period. Riverbridge Partners LLC owned approximately 0.88% of Option Care Health worth $34,625,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in OPCH. UMB Bank n.a. increased its holdings in Option Care Health by 937.5% in the 3rd quarter. UMB Bank n.a. now owns 830 shares of the company's stock valued at $26,000 after purchasing an additional 750 shares in the last quarter. GAMMA Investing LLC increased its position in shares of Option Care Health by 110.6% during the third quarter. GAMMA Investing LLC now owns 897 shares of the company's stock worth $28,000 after acquiring an additional 471 shares during the last quarter. Whittier Trust Co. of Nevada Inc. increased its position in shares of Option Care Health by 3,362.8% during the third quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company's stock worth $47,000 after acquiring an additional 1,446 shares during the last quarter. International Assets Investment Management LLC increased its position in shares of Option Care Health by 3,029.7% during the third quarter. International Assets Investment Management LLC now owns 2,848 shares of the company's stock worth $91,000 after acquiring an additional 2,757 shares during the last quarter. Finally, Quarry LP increased its position in shares of Option Care Health by 327.7% during the third quarter. Quarry LP now owns 3,430 shares of the company's stock worth $107,000 after acquiring an additional 2,628 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Option Care Health Stock Up 2.3 %

NASDAQ:OPCH traded up $0.67 during mid-day trading on Thursday, reaching $29.98. The stock had a trading volume of 1,361,070 shares, compared to its average volume of 2,279,676. The company has a market capitalization of $5.10 billion, a price-to-earnings ratio of 25.19, a price-to-earnings-growth ratio of 2.12 and a beta of 1.31. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $34.63. The stock's 50 day simple moving average is $24.10 and its two-hundred day simple moving average is $27.78. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32.

Insider Buying and Selling at Option Care Health

In related news, Director Harry M. Jansen Kraemer, Jr. bought 43,000 shares of the firm's stock in a transaction on Friday, November 8th. The stock was bought at an average cost of $22.54 per share, for a total transaction of $969,220.00. Following the completion of the purchase, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. The trade was a 15.18 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.64% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

A number of brokerages have recently issued reports on OPCH. The Goldman Sachs Group lowered Option Care Health from a "buy" rating to a "neutral" rating and dropped their target price for the stock from $38.00 to $27.00 in a research report on Monday, November 4th. Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and lifted their target price for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. UBS Group began coverage on Option Care Health in a research report on Thursday, December 5th. They set a "neutral" rating and a $26.00 target price on the stock. JMP Securities reaffirmed a "market outperform" rating and set a $30.00 target price (down from $31.00) on shares of Option Care Health in a research report on Friday, January 10th. Finally, Jefferies Financial Group upgraded Option Care Health from a "hold" rating to a "buy" rating and lifted their price target for the stock from $26.00 to $35.00 in a research note on Thursday. Two equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $31.14.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.